Since 2010, the Global Law Experts annual awards have been celebrating excellence, innovation and performance across the legal communities from around the world.
posted 2 hours ago
Whether an EGM is required for rights issues in Egypt depends on the scope of authority the company’s articles of association (AoA) delegate to the board and on the specific capital-increase mechanism chosen. Under Companies Law No. 159 of 1981, the primary statute governing joint stock companies, a capital increase by rights issue generally requires an extraordinary general meeting resolution unless the AoA expressly empower the board to increase capital within defined limits.
The 2026 amendments to the Financial Regulatory Authority’s (FRA) listing and delisting rules have introduced additional auditor-confirmation and governance requirements that affect both documentation timelines and the circumstances in which the Egyptian Exchange (EGX) may insist on shareholder approval even where the Companies Law might otherwise permit board action. This guide consolidates statutory rules, EGX/FRA practice and step-by-step filing logistics into a single reference for issuers, advisers and company secretaries navigating a rights issue on the EGX in 2026.
Quick checklist, what this article covers:
Companies Law No. 159 of 1981 and its executive regulations set out the framework for capital increases. The statute provides that increasing the issued share capital of a joint stock company is a matter that amends the company’s constitutional documents and therefore falls, by default, within the competence of the extraordinary general meeting. The same law enshrines pre-emption rights for existing shareholders: when new shares are issued for cash, current holders must be offered the right to subscribe in proportion to their existing stakes before shares can be offered to third parties. These statutory pre-emption rights in Egypt are a cornerstone of minority shareholders’ protection and can only be disapplied through a valid shareholder resolution.
Crucially, however, the Companies Law permits the AoA of a joint stock company to delegate to the board the authority to resolve on capital increases within specified parameters, for example, up to a stated percentage of authorised capital, within a defined time window, or subject to a price floor. Where such delegation exists and has not been exhausted, the board may approve a rights issue without convening an extraordinary general meeting.
Even where the AoA contain a delegation clause, certain circumstances will require the issuer to return to shareholders via an EGM. The most frequent triggers include:
Advisers can apply a three-step rule of thumb to determine whether an EGM is required for a rights issue in Egypt:
For a rights issue on the EGX, the issuer must submit a comprehensive filing package to the exchange. This typically includes certified copies of the relevant board or EGM resolution, a letter of offer (or a prospectus, where the issue size or circumstances require one), updated audited financial statements, a legal adviser’s confirmation of the validity of the corporate authorisation, and instructions to the central depository (Misr for Central Clearing, Depository and Registry, MCDR) for establishing a record date and generating a new ISIN for the tradeable rights entitlements. The EGX will not admit the new shares to listing until it has received evidence that all statutory and regulatory approvals have been obtained and all subscription mechanics are in place.
The FRA’s 2026 amendments to the listing and delisting rules, designed to strengthen governance and investor protection, have introduced several changes with direct relevance to rights issues. Industry observers expect the practical effects to include:
These FRA amendments to the EGX listing rules reinforce the need for issuers to engage auditors and legal advisers earlier in the process than was previously standard practice.
Market practice shows that the EGX may require evidence of shareholder approval in situations where the rights issue materially changes the company’s listing characteristics, for example, where the issue would dilute existing free float below minimum listing thresholds, where the issue is coupled with a change in the company’s sector classification, or where the pricing terms raise investor-protection concerns. In these cases, even a technically valid board delegation may be insufficient to satisfy the EGX listing requirements, and the issuer will be directed to obtain an EGM resolution before proceeding with the capital increase on the EGX.
The following timeline illustrates how to apply for a rights issue on the EGX, from initial board decision to trading of the new shares. Actual timings depend on whether an EGM is needed and on FRA/EGX review periods.
| Stage | Indicative timing | Key actions |
|---|---|---|
| 1. Board Meeting 1 | Day 0 | Resolve to pursue the capital increase. If AoA delegation exists and limits are not exceeded, approve the rights issue directly. If not, resolve to convene an EGM. Engage legal adviser and auditor. |
| 2. EGM notice | Day 1–15 | Publish notice in the Commercial Gazette and a daily newspaper. The notice period under the Companies Law is a minimum of 15 days before the meeting date. Include agenda, proposed resolution text, venue and quorum details. |
| 3. EGM | Day 15–20 | Hold the extraordinary general meeting. Achieve the required quorum and voting threshold. Record minutes, have them notarised and submit certified copies to the Commercial Registry and the General Authority for Investment and Free Zones (GAFI). |
| 4. Board Meeting 2 | Day 20–25 | Ratify allotment terms: fix the issue ratio, subscription price, renunciation rights, subscription period duration and record date. |
| 5. Letter of Offer / Prospectus preparation | Day 25–40 | Draft the letter of offer (or prospectus). Obtain auditor confirmations and legal-adviser declarations as required by the 2026 FRA rules. Submit draft to FRA for review. |
| 6. EGX filing and FRA notification | Day 40–50 | File the full submission package with the EGX: certified board/EGM minutes, letter of offer, auditor and legal confirmations, MCDR instructions. Notify the FRA formally. |
| 7. Record date and ISIN creation | Day 50–55 | MCDR establishes the record date. Shareholders on the register at the record date receive rights entitlements. A new ISIN is generated for the tradeable rights. |
| 8. Trading and subscription | Day 55–75+ | Rights trade on the EGX during the renunciation window (typically 10–15 trading days). Subscription period runs concurrently or immediately after. At close of subscription, unsubscribed shares are allocated per the terms of the offer. |
| 9. Allotment and settlement | Day 75–85+ | Board confirms final allotment. MCDR converts rights ISINs to ordinary-share ISINs. New shares are admitted to listing and begin trading. |
Documents requiring original certified copies for EGX/FRA filing:
Pre-emption rights in Egypt are statutory: under Companies Law No. 159/1981, existing shareholders of a joint stock company are entitled to subscribe for new shares issued for cash in proportion to their existing holdings. These rights attach automatically and do not require activation by the board or AoA. However, pre-emption can be waived by an extraordinary general meeting resolution, a critical point for issuers considering whether a full rights issue or a targeted private placement better serves the company’s capital-raising objectives.
| Issue | Rights Issue | Private Placement |
|---|---|---|
| Shareholder pre-emption | Existing shareholders have statutory pre-emption unless validly waived by EGM resolution | No statutory pre-emption applies; however, contractual or AoA-level restrictions may exist |
| Approval threshold | EGM required if AoA do not delegate authority or if delegation limits are exceeded; board resolution suffices where valid delegation exists | Usually board resolution plus shareholder notice, depending on AoA and FRA-regulated rules |
| EGX/FRA treatment | Requires EGX filing, letter of offer, ISIN for rights; EGX may require EGM approval for certain listing changes | EGX pre-clearance may be needed for listed companies; different disclosure and lock-up expectations apply |
Drafting pre-emption waivers. A waiver resolution should specify the exact number of shares to which pre-emption is being waived, the identity of the proposed allottees (if known), and the pricing basis. Record the full text in notarised EGM minutes and file with both the Commercial Registry and the FRA. Failure to follow this procedure can expose the issuer to challenges from minority shareholders.
Several recurring pitfalls delay or derail rights issues on the EGX. Advisers should be alert to the following:
The following templates provide starting-point language. Each must be adapted to the company’s specific AoA, the terms of the proposed capital increase, and the requirements of the EGX and FRA at the time of filing.
1. Board resolution, capital increase under delegated authority
“RESOLVED that, pursuant to Article [●] of the Company’s Articles of Association and within the limits of the authority delegated to the Board by the Extraordinary General Meeting held on [date], the Board hereby approves an increase in the Company’s issued share capital from EGP [●] to EGP [●] by the issuance of [●] new ordinary shares of EGP [●] nominal value each, to be offered to existing shareholders by way of rights issue at a subscription price of EGP [●] per share.”
2. EGM resolution, capital increase requiring shareholder approval
“RESOLVED, by way of extraordinary resolution, that the issued share capital of the Company be increased from EGP [●] to EGP [●] by the creation and allotment of [●] new ordinary shares of EGP [●] nominal value each, to be offered to existing shareholders pro rata to their holdings by way of rights issue, at a subscription price of EGP [●] per share, and that Article [●] of the Company’s Articles of Association be amended accordingly.”
3. EGM resolution, waiver of pre-emption rights
“RESOLVED, by way of extraordinary resolution, that the statutory pre-emption rights of existing shareholders under Companies Law No. 159 of 1981 be waived in respect of [●] new ordinary shares of EGP [●] nominal value each, to be allocated to [identify allottees or describe allocation basis] at a subscription price of EGP [●] per share, and that the Board be authorised to take all steps necessary to implement this resolution.”
The requirement for an extraordinary general meeting in Egypt varies by entity type. The following table summarises the position for the three most common corporate structures.
| Entity type | When EGM is needed for a capital increase | Typical required vote |
|---|---|---|
| Listed joint stock company (SAE, listed on EGX) | Required unless AoA delegate authority to the board within defined limits; EGX may impose additional shareholder-approval conditions | Extraordinary resolution, typically a two-thirds supermajority of shares represented at the meeting, subject to quorum |
| Unlisted joint stock company (SAE, not listed) | Required unless AoA delegation exists; no EGX overlay, but GAFI and Commercial Registry filings still apply | Two-thirds supermajority of shares represented, subject to quorum requirements under the Companies Law |
| Limited liability company (LLC) | Partners’ meeting required for any amendment to the memorandum of association, including capital increases; no delegated-authority mechanism equivalent to SAE practice | Approval of partners holding at least three-quarters of the company’s capital (unless the memorandum specifies a higher threshold) |
For issuers structured as joint stock companies and listed on the EGX, the interaction between the Companies Law, the AoA delegation clause and EGX listing requirements creates the most complex approval matrix. Advisers should map all three layers before advising on whether an EGM is required for the specific rights issue under consideration.
The following checklist distils the key decision points and red flags that force an EGM for a capital increase on the EGX:
Red flags that always force an EGM: no AoA delegation clause; delegation exhausted or expired; AoA amendment needed; new share class; pre-emption waiver; EGX direction based on listing-eligibility concerns.
Determining whether an EGM is required for rights issues in Egypt is not a binary question, it hinges on the interplay between the company’s AoA delegation clause, the scope of the proposed capital increase, and the regulatory overlay imposed by the EGX and the FRA. The 2026 FRA listing-rule amendments have raised documentation standards and compressed review timelines, making early adviser engagement essential. Issuers planning a capital increase on the EGX should map the three-layer approval test set out in this guide, prepare filings to the 2026 standard from the outset, and build a realistic 60-to-85-day timeline into their capital-raising plans.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Omneya Anas at Shalakany, a member of the Global Law Experts network.
Find the right Legal Expert for your business
Sign up for the latest advisor briefings and news within Global Advisory Experts’ community, as well as a whole host of features, editorial and conference updates direct to your email inbox.
Naturally you can unsubscribe at any time.
Global Advisory Experts is dedicated to providing exceptional advisory services to clients around the world. With a vast network of highly skilled and experienced advisors, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
